Thousand Oaks-based Amgen Inc. will collaborate with Abilita Bio, a privately held biotech company in San Diego focused on discovery and development of drugs targeting membrane proteins, according to a press release Wednesday....

Join our Membership to get the full story.


Are you a current Member? Sign In